- Home
- / Vectus Biosystems
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Vectus Biosystems financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.1
2024-10-14
Market Capitalization
$4.3 M
2024-10-14
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| AUD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | 9.0K | 50.0K | 1.0M | 1.3M | 1.3M | 1.1M | 461.0K | |
| Operating expense total | 4.0M | 2.4M | 2.7M | 3.8M | 4.6M | 4.5M | 3.4M | 2.2M |
| Depreciation and amortization | 20.0K | 23.0K | 20.0K | 17.0K | 20.0K | 47.0K | 59.0K | 14.0K |
| EBITDA | (4.0M) | (2.3M) | (2.6M) | (2.8M) | (3.3M) | (3.2M) | (2.3M) | (1.7M) |
| EBIT | (4.0M) | (2.4M) | (2.7M) | (2.8M) | (3.3M) | (3.3M) | (2.4M) | (1.7M) |
| Interest income | 2.0K | 56.0K | 77.0K | 19.0K | ||||
| Interest expense | 23.0K | 123.0K | 716.0K | 1.1M | 693.0K | 206.0K | 9.0K | 4.0K |
| Pre tax profit | (4.0M) | (2.5M) | (3.4M) | (3.9M) | (4.0M) | (3.4M) | (2.3M) | (1.8M) |
| Income tax expense | (1.4M) | (900.0K) | (384.0K) | |||||
| Net Income | (2.6M) | (1.6M) | (3.0M) | (3.9M) | (4.0M) | (3.4M) | (2.3M) | (1.8M) |